AmerisourceBergen - ABC Stock Forecast, Price & News

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Analyst Ratings Changes

ABC has been the subject of a number of recent research reports. Argus boosted their price objective on AmerisourceBergen from $160.00 to $170.00 and gave the company a "buy" rating in a research note on Wednesday, July 20th. Mizuho increased their price objective on shares of AmerisourceBergen from $139.00 to $162.00 in a research note on Thursday, May 5th. Robert W. Baird lifted their target price on shares of AmerisourceBergen from $179.00 to $187.00 in a research note on Thursday, May 5th. Cowen cut their price target on AmerisourceBergen from $171.00 to $170.00 in a research note on Thursday, June 9th. Finally, Credit Suisse Group lowered their price objective on AmerisourceBergen from $180.00 to $175.00 and set an "outperform" rating on the stock in a research report on Thursday, August 4th. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $173.45.

AmerisourceBergen Price Performance

Shares of NYSE:ABC traded up $2.73 during mid-day trading on Friday, reaching $150.50. The stock had a trading volume of 880,952 shares, compared to its average volume of 994,437. The company has a market cap of $31.52 billion, a P/E ratio of 17.26, a price-to-earnings-growth ratio of 1.64 and a beta of 0.48. The business's 50 day moving average price is $143.29 and its 200 day moving average price is $147.85. The company has a current ratio of 0.92, a quick ratio of 0.55 and a debt-to-equity ratio of 8.96. AmerisourceBergen has a 1 year low of $113.68 and a 1 year high of $167.19.

AmerisourceBergen (NYSE:ABC - Get Rating) last posted its earnings results on Wednesday, August 3rd. The company reported $2.62 EPS for the quarter, beating analysts' consensus estimates of $2.56 by $0.06. AmerisourceBergen had a return on equity of 350.60% and a net margin of 0.78%. The firm had revenue of $60.06 billion during the quarter, compared to the consensus estimate of $59.03 billion. During the same period in the prior year, the company earned $2.16 EPS. The company's quarterly revenue was up 12.5% compared to the same quarter last year. Research analysts expect that AmerisourceBergen will post 10.99 EPS for the current fiscal year.

AmerisourceBergen Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 29th. Investors of record on Monday, August 15th will be given a $0.46 dividend. The ex-dividend date is Friday, August 12th. This represents a $1.84 annualized dividend and a yield of 1.22%. AmerisourceBergen's dividend payout ratio is currently 21.10%.

Insiders Place Their Bets

In other news, CEO Steven H. Collis sold 11,480 shares of AmerisourceBergen stock in a transaction that occurred on Tuesday, July 12th. The stock was sold at an average price of $142.35, for a total value of $1,634,178.00. Following the completion of the transaction, the chief executive officer now owns 205,178 shares in the company, valued at approximately $29,207,088.30. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders have sold 34,440 shares of company stock valued at $4,911,374 over the last ninety days. 28.40% of the stock is owned by insiders.